Concurrent with this announcement, Amarantus has a

Concurrent with this announcement, Amarantus has acquired certain assets of Regenicin (OTCQB:RGIN), including rights to the pending litigation Regenicin brought against Lonza that was filed in the Superior Court of Fulton County, State of Georgia, which lawsuit was subsequently removed to the United States District Court for Northern Georgia (CV:1:13-CV-3569), and subsequently transferred to the United States District Court for New Jersey (CV:1:14-CV-02775) and is currently pending, and certain trademarks and know-how related to ESS. Upon exercise of the Lonza Option, Amarantus will dismiss the litigation with prejudice.